Search Results for: yamanaka

Recommended regenerative medicine reads plus COVID-19 stem cell hype

Universal-Cells

Despite the COVID-19 pandemic there are still some research things we can do including data analysis as well as reading new papers and media articles on science, including regenerative medicine. If the weather’s good and you have wi-fi (or you print articles still on paper) you can even do this out in the fresh air […]

Recommended regenerative medicine reads plus COVID-19 stem cell hype Read More »

IPS cell field update: easy culture, Parkinson’s, scarring, immune cells, & mutations

Fibrosis-model-IPS-cells-Fig-1b-Vijayaraj-et-al-Cell-Reports-2019

Where do things stand today in 2020 with IPS cell research? It’s been 14 years since they were first reported, but they continue to make news. Back in 2006 I was wrapping up my postdoc with Bob Eisenman at The Hutch in Seattle, largely studying Myc, when Shinya Yamanaka published his first induced pluripotent stem

IPS cell field update: easy culture, Parkinson’s, scarring, immune cells, & mutations Read More »

Stem cell pioneer Masayo Takahashi (高橋 政代) leaves RIKEN

Masayo-Takahashi

In a surprise, Dr. Masayo Takahashi has announced that she has left RIKEN. Takahashi indicates she will be new President of a company called Vision Care, Inc. as part of the Kobe Eye Center. I’ve pasted a picture of Takahashi’s Tweet with translation more toward the bottom of the post. A big thanks to Piero

Stem cell pioneer Masayo Takahashi (高橋 政代) leaves RIKEN Read More »

Japan stem cell clinical studies rapidly piling up

Shibata-et-al.-Cell-reports-2018-corneal-structures-made-from-hIPSCs

Japan is a leader in stem cell and regenerative medicine research, and in particular in clinical translation toward the bedside. Induced pluripotent stem cell (IPSC)-based investigational therapies are rightly an area of focus in Japan given their invention by Nobel Laureate Shinya Yamanaka. Small clinical studies based on IPSC have been initiated there for several

Japan stem cell clinical studies rapidly piling up Read More »

Perspectives on high-profile stem cell retraction in the making from Kyoto University

IPS-cell-paper-retraction-requested

A researcher working at Kyoto University has reportedly engaged in misconduct leading to an institutional request for retraction of a paper from the journal Stem Cell Reports. The paper in question appears to have rather large-scale problems: “Kohei Yamamizu, a specially appointed assistant professor at the university’s Center for iPS Cell Research and Application, falsified all

Perspectives on high-profile stem cell retraction in the making from Kyoto University Read More »

On the threshold of cell therapy for Parkinson’s disease

Dopamine-neurons-derived-from-a-Parkinsons-disease-patients-iPSCs-Tyrosine-hydroxylase-1

By Jeanne Loring There are ten million people in the world who have Parkinson’s disease. 125,000 of these are living in California.  People with the disease often have to step away from their jobs because the main symptoms – tremor or freezing up of muscles – make it difficult to get through a whole day

On the threshold of cell therapy for Parkinson’s disease Read More »